DCF — ASPIRUS STANLEY HOSPITAL
Enterprise Value: $-14.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-14.7M
Enterprise Value
$-5.0M
PV of Cash Flows
$-9.7M
PV of Terminal Value
$-15.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $20.5M | $-0.7M | -3.0% | $-1.6M | $-1.4M |
| Year 2 | $21.1M | $-0.5M | -2.0% | $-1.4M | $-1.2M |
| Year 3 | $21.8M | $-0.3M | -1.0% | $-1.2M | $-0.9M |
| Year 4 | $22.4M | $-0.2M | -1.0% | $-1.2M | $-0.8M |
| Year 5 | $23.1M | $-0.2M | -1.0% | $-1.1M | $-0.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-14.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$19.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.039504266716559454
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5